Skip to main content

In8bio Inc (INAB) Stock

In8bio Inc Stock Details, Movements and Public Alerts

Stock Details

In8bio Inc (INAB), a prominent company in the healthcare sector within the biotechnology industry, is based in USA and primarily trades on the NASDAQ.Currently, the stock is trading at $2.06. Over the past 52 weeks, it has ranged between $1.17 and $7.50. This places the current price at 27.5% of its 52-week high and 76.1% above its 52-week low. Recent trading volume was recorded at 95,499. The 14-day Relative Strength Index (RSI) stands at 42.42, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $1.99 by 3.52%. Similarly, it is below its 200-day moving average of $2.25 by 8.44%. The MACD histogram is -0.01, indicating bearish momentum (MACD Line: -0.12, Signal Line: -0.12).

52-Week Range

$7.50 - $1.17

-72.53% from high · +76.07% from low

Avg Daily Volume

39,861

20-day average

100-day avg: 195,979

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Price to Book

1.40

EV/EBITDA

-1.15

EPS (TTM)

-$5.26

Beta

0.00

Less volatile than market

Q:How is INAB valued relative to its earnings and growth?
Valuation data is not available for this stock.
Q:What is INAB's risk profile compared to the market?
With a beta of 0.00, In8bio Inc is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability. The price-to-book ratio of 1.40 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

0.00%

Operating Margin

0.00%

EBITDA

$-19,160,000

Return on Equity

-189.70%

Return on Assets

-80.40%

Revenue Growth (YoY)

0.00%

Earnings Growth (YoY)

0.00%

Q:How profitable and efficient is INAB's business model?
Profitability metrics are not available for this stock.
Q:What are INAB's recent growth trends?
Growth data is not available for this stock.

Company Size & Market

Market Cap

$18.5M

Revenue (TTM)

$0

Revenue/Share (TTM)

$0.00

Shares Outstanding

9.77M

Book Value/Share

$2.87

Asset Type

Common Stock

Q:What is INAB's market capitalization and position?
In8bio Inc has a market capitalization of $18.5M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 9.77M shares outstanding, the company's ownership is relatively concentrated. As a participant in the BIOTECHNOLOGY industry, it competes with other firms in this sector.
Q:How does INAB's price compare to its book value?
In8bio Inc's book value per share is $2.87, while the current stock price is $2.06, resulting in a price-to-book (P/B) ratio of 0.72. Trading below book value can indicate the market perceives challenges ahead, or it might represent a value opportunity if the assets are quality and earnings can recover. Value investors often screen for P/B ratios below 1.0. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$6.25

203.40% upside potential

Analyst Recommendations

Strong Buy

1

Buy

3

Hold

0

Sell

0

Strong Sell

0

Q:How reliable are analyst predictions for INAB?
4 analysts cover INAB with 100% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $6.25 implies 203.4% upside, but targets are often adjusted to follow price moves rather than predict them.
Q:What is the Wall Street consensus on INAB?
Current analyst recommendations:1 Strong Buy, 3 Buy, 000The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Mar 15, 2026, 02:26 AM

Technical Indicators

RSI (14-day)

42.42

Neutral

50-Day Moving Average

$1.99

3.52% above MA-50

200-Day Moving Average

$2.25

-8.44% below MA-200

MACD Line

-0.12

MACD Signal

-0.12

MACD Histogram

-0.01

Bearish

Q:What does INAB's RSI value tell investors?
The RSI (Relative Strength Index) for INAB is currently 42.42, indicating the stock is in neutral territory (40-60 range). Neither buyers nor sellers have clear control, suggesting consolidation or balanced market forces. Combined with the price being above the 50-day moving average, this shows mixed signals requiring careful analysis.
Q:How should traders interpret INAB's MACD and moving average crossovers?
MACD analysis shows the MACD line at -0.12 below the signal line at -0.12, with histogram at -0.01. This bearish crossover indicates downward pressure. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($1.99) is below the 200-day MA ($2.25), forming a death cross pattern that often warns of extended weakness. Price is currently between the MAs, suggesting transition.

Indicators last updated: Mar 2, 2026, 04:31 AM

Active Alerts

No active alerts for this stock.

Be the first to set up an alert for INAB and get notified when the price changes.

Stay Ahead of the Market with In8bio Inc Alerts

Set up price alerts for In8bio Inc and get notified instantly when the price hits your target. Never miss an important price movement again.